Satellos Bioscience Revenue

Revenue

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

84.40M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	-	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Veradigm	588.02M
Elite Pharmaceuticals	105.45M
Tian'an Technology Group	2.12M
Glass House Brands	221.55M
Northwest Biotherapeutics	1.09M
American Oncology Network	1.76B
Silence Therapeutics	27.17M
Longduoduo Company	4.99M

Revenue Rankings

Satellos Bioscience News

1 day ago - Satellos Bioscience: Promising Novel Treatment For Duchenne Muscular Dystrophy - Seeking Alpha
14 days ago - Satellos to Participate in Four September Institutional and Retail Investor Conferences - Business Wire
22 days ago - Satellos Reports Second Quarter 2025 Results and Highlights Upcoming Clinical Milestones - Business Wire
4 weeks ago - Satellos to Present at Canaccord Genuity's 45th Annual Growth Conference - Business Wire
2 months ago - Satellos Bioscience Shareholders Elect Two New Board Members - Business Wire
2 months ago - Satellos Bioscience Announces Results of Annual and Special Meeting of Shareholders - Business Wire
2 months ago - Satellos Bioscience to Participate in PPMD's Annual Conference in Las Vegas - Business Wire
3 months ago - Satellos Announces Encouraging Functional Data from the 28-day Phase 1b Open-Label Trial of SAT-3247 in Adults with Duchenne Muscular Dystrophy - Business Wire

More News